How long does it take to lose 20kg on Wegovy?

You've set a 20kg goal, here's where most people find themselves at each stage

Picture the first eight weeks. The dose is low, your body is adjusting, and the scales might not have moved much yet. This is normal and not a sign treatment isn't working. Semaglutide needs time to titrate up to a therapeutic level, and the early weeks are mostly about tolerability rather than dramatic results. Most people start to notice meaningful appetite reduction somewhere around weeks eight to twelve, once they reach the 1mg or 1.7mg stage.

By three to four months, many people have lost four to six kilograms. Progress tends to feel steady and gradual rather than steep. Six months in, especially once the 2.4mg maintenance dose is established, losses of eight to twelve kilograms are common in trial populations. That puts 20kg firmly on the horizon, but not yet in reach for most people at this point.

The bulk of total weight loss in the STEP 1 trial published in the New England Journal of Medicine accumulated between weeks 20 and 52, with results continuing to improve out to 68 weeks. The practical message: 20kg is most often a 12-to-18-month outcome, not a six-month one. Expecting to be there at week 12 sets up frustration; expecting to see real progress by then is entirely reasonable. If you want a closer look at the general weight-loss timeline, this page on how long weight loss takes on Wegovy covers the broader picture.

Why some people reach 20kg and others don't, what actually drives the difference

Starting weight matters more than most people expect. If your baseline is 100kg, losing 20kg means losing 20% of your body weight, above the trial average. If you start at 140kg, 20kg is 14%, well within typical trial results. This isn't a motivation issue; it's arithmetic. The same medicine, the same dose, the same effort can produce very different absolute losses depending on where you begin.

Alongside starting weight, a few other factors genuinely shift where you land. People who manage to maintain a reduced-calorie diet throughout tend to lose more. Those who experience more pronounced appetite suppression (which varies between individuals regardless of dose) often lose weight more quickly in the first six months. Sleep, stress, medication interactions and underlying metabolic conditions all play a role that a prescriber is better placed to discuss than any general guide.

There is a common misconception worth addressing here: that if you aren't losing weight every single week, something has gone wrong. Weight loss on semaglutide is not linear. Weeks where the number barely moves are a normal part of the pattern, and they do not predict the final outcome. The plateau (when loss genuinely slows for a sustained period) is a different thing, and it usually appears much later, around month 12 or beyond. If you are curious about how long it typically takes to lose 10kg on Wegovy, that page gives a useful halfway-point reference for people with larger targets. Understanding what drives early results on Wegovy can help set more grounded expectations from the start.

The new 7.2mg dose and what it means for people with larger weight-loss targets

In April 2026, the MHRA approved a dedicated single-dose 7.2mg Wegovy pen, a higher maintenance dose than the long-standing 2.4mg. Trial data at this higher dose reported average weight loss of around 20.7% over 72 weeks, which meaningfully closes the gap with tirzepatide's results and makes a 20kg outcome more attainable for a wider range of people, including some with lower starting weights.

The titration schedule still begins at 0.25mg; 7.2mg is the ceiling, not the starting point. The MHRA's announcement of the 7.2mg pen approval confirms it is licensed for adults with a BMI of 30 or above. Whether that higher dose is right for a particular person is a clinical decision made with a prescriber, not something to select from a drop-down menu.

For anyone wondering about the cost of treatment over this kind of timeframe, the Wegovy pricing page explains how private treatment is structured. What matters clinically is that the dose a prescriber recommends is based on your response and tolerability, not on what you've budgeted for.

What to do if progress toward 20kg feels slow or has stalled

If you are six months into treatment and feel a long way from 20kg, the most useful thing is a frank conversation with your prescriber rather than a Google search for reassurance. There are real clinical questions worth asking: is the dose optimal, is there anything blunting the medicine's effect, are there lifestyle factors that could shift with some support? These are exactly the conversations a good prescribing service builds in.

The NICE appraisal of semaglutide for weight management suggests that if less than 5% weight loss has occurred after six months at the maintenance dose, continuing the medicine should be reviewed. That is a clinical checkpoint, not a deadline, and it underlines why ongoing prescriber involvement matters throughout treatment, not just at the start.

If you are considering whether to begin treatment or want to understand whether Wegovy is the right option given your specific situation, our prescribers are available to discuss it. How quickly Wegovy begins to work is a related question that often comes up at this stage too. You can also explore the full range of weight-loss treatments we offer to see what fits your circumstances. When you are ready, starting a free consultation is the first step toward a proper clinical assessment.